Filter Results:
(96)
Show Results For
- All HBS Web
(635)
- People (4)
- News (96)
- Research (426)
- Events (3)
- Multimedia (4)
- Faculty Publications (259)
Show Results For
- All HBS Web
(635)
- People (4)
- News (96)
- Research (426)
- Events (3)
- Multimedia (4)
- Faculty Publications (259)
Page 1 of 96
Results →
Sort by
- 01 Mar 2007
- News
Daniel Vasella
that had been separate. On a global basis we created project teams to move drugs forward. That allowed us to have more approvals by the FDA than any other major pharmaceutical company since the year 2000.... View Details
- 01 Oct 2020
- News
Does Your Company Need a Chief Medical Officer?
- 01 Mar 2007
- News
Pharma Suits a Farm Gal
GRAHAM: From rodeo to CEO. Amylin Pharmaceuticals CEO Ginger Graham (MBA ’86) had a good year in 2006, with Amylin stock up as much as 45 percent, with Byetta and Symlin, its two innovative diabetes drugs, performing well, and with the... View Details
- 01 Dec 2013
- News
Your Own Medicine
help build new muscle—had been one of several potential treatments the Secklers chased to no avail, often stuck following promising science to dead ends. That changed three years ago, when former pharmaceutical executive Gene Williams... View Details
- 28 Feb 2020
- News
Filling the White Space
companies involved in research into psychedelic compounds for medical use. (Compass has been granted a US patent that covers a method of obtaining psilocybin to treat drug-resistant depression; the treatment is in a phase IIb clinical... View Details
- 20 Mar 2015
- News
Big Pharma Needs to Get Busy in the Lab
- 22 Sep 2015
- News
Should Bank of America's CEO also be the chairman?
- 09 Nov 2011
- News
Resistance Is Futile
- 26 Apr 2010
- News
Pharma's Future Depends on These Three Trends
- 01 Oct 2011
- News
Resistance Is Futile
- 15 Feb 2011
- News
Who will blink in Genzyme, Sanofi price talks?
- 27 Nov 2021
- News
The Bright New Age of Venture Capital
- 15 Feb 2018
- News
Does CVS–Aetna Spell the End of Business as Usual?
- 26 Feb 2012
- News
Can brand Mallya make Kingfisher Airlines fly?
- 11 Apr 2019
- News
The DNA of Sustained Innovation
- 13 Jul 2023
- News
The Network Effect
between the two companies. In March 2021, Model was a part of the Agios team that finalized the sale of the biotech’s oncology portfolio to international pharmaceutical company Servier. For Agios, the sale... View Details